Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Short-term Activity Ratios (Summary)
Turnover Ratios
Average No. Days
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
The analysis of operating activity ratios from 2018 to 2022 reveals a period of significant volatility in operational efficiency, characterized by a marked decline in inventory management performance peaking in 2021, followed by a recovery in 2022.
- Inventory Management Efficiency
- A substantial decline in inventory turnover is observed from 5.20 in 2018 to a low of 2.15 in 2021. This deterioration is mirrored in the average inventory processing period, which expanded from 70 days in 2018 to 170 days in 2021. However, 2022 shows a corrective trend, with the turnover ratio improving to 3.35 and the processing period reducing to 109 days, indicating an optimization of stock levels or an increase in sales velocity.
- Receivables and Payables Management
- Receivables turnover remained relatively stable throughout the period, though a slight downward trend is noted by 2022, with the collection period increasing to 89 days from a low of 71 days in 2019. Simultaneously, the average payables payment period saw an extension from 75 days in 2018 to a peak of 93 days in 2021, before contracting to 85 days in 2022. This suggests a strategy of extending payment terms to suppliers to offset liquidity pressures during the period of slower inventory turnover.
- Operating and Cash Conversion Cycles
- The operating cycle experienced a significant expansion, rising from 150 days in 2018 to 247 days in 2021, primarily driven by the increase in inventory holding times. Consequently, the cash conversion cycle peaked at 154 days in 2021, up from 75 days in 2018. By 2022, the cash conversion cycle improved to 113 days, reflecting a more efficient transition from cash outflows for resources to cash inflows from sales.
- Working Capital Utilization
- Working capital turnover remained low and relatively flat between 2018 and 2021, fluctuating between 0.69 and 0.92. A notable shift occurred in 2022, where the ratio increased sharply to 1.59. This indicates a significant improvement in the ability to generate revenue relative to the investment in working capital.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Inventory Turnover
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Cost of sales | 1,026,700) | 768,000) | 646,600) | 544,500) | 367,700) | |
| Inventory | 306,700) | 357,300) | 234,700) | 119,800) | 70,700) | |
| Short-term Activity Ratio | ||||||
| Inventory turnover1 | 3.35 | 2.15 | 2.76 | 4.55 | 5.20 | |
| Benchmarks | ||||||
| Inventory Turnover, Competitors2 | ||||||
| Abbott Laboratories | 3.10 | 3.59 | — | — | — | |
| Intuitive Surgical Inc. | 2.27 | 2.98 | — | — | — | |
| Medtronic PLC | 2.20 | 2.43 | — | — | — | |
| Inventory Turnover, Sector | ||||||
| Health Care Equipment & Services | 30.70 | 31.85 | — | — | — | |
| Inventory Turnover, Industry | ||||||
| Health Care | 7.85 | 7.90 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Inventory turnover = Cost of sales ÷ Inventory
= 1,026,700 ÷ 306,700 = 3.35
2 Click competitor name to see calculations.
Between 2018 and 2022, a significant expansion in the cost of sales occurred, rising from $367.7 million to over $1.02 billion. This growth was accompanied by a period of declining inventory efficiency that reached its lowest point in 2021 before showing signs of recovery in 2022.
- Cost of Sales Trajectory
- A consistent upward trend is observed in the cost of sales throughout the analyzed period. The most substantial year-over-year increase occurred between 2021 and 2022, where expenses rose by approximately 33.8%, indicating a significant scale-up in operations or production volume.
- Inventory Level Fluctuations
- Inventory holdings grew aggressively from $70.7 million in 2018 to a peak of $357.3 million in 2021. This build-up suggests a strategy of stockpiling or a response to anticipated demand growth. However, a reversal occurred in 2022, with inventory levels decreasing to $306.7 million, indicating a potential optimization of stock levels.
- Inventory Turnover Performance
- The inventory turnover ratio experienced a sustained decline from 5.20 in 2018 to 2.15 in 2021, signaling that inventory remained on hand for longer periods and that inventory growth outpaced the growth in cost of sales. In 2022, the ratio improved to 3.35, reflecting an increase in operational efficiency and a more rapid conversion of inventory into sales.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Receivables Turnover
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Revenue | 2,909,800) | 2,448,500) | 1,926,700) | 1,476,000) | 1,031,600) | |
| Accounts receivable, net | 713,300) | 514,300) | 428,500) | 286,300) | 226,700) | |
| Short-term Activity Ratio | ||||||
| Receivables turnover1 | 4.08 | 4.76 | 4.50 | 5.16 | 4.55 | |
| Benchmarks | ||||||
| Receivables Turnover, Competitors2 | ||||||
| Abbott Laboratories | 7.02 | 6.64 | — | — | — | |
| Elevance Health Inc. | 18.81 | 20.66 | — | — | — | |
| Intuitive Surgical Inc. | 6.60 | 7.30 | — | — | — | |
| Medtronic PLC | 5.71 | 5.51 | — | — | — | |
| UnitedHealth Group Inc. | 18.22 | 20.07 | — | — | — | |
| Receivables Turnover, Sector | ||||||
| Health Care Equipment & Services | 14.33 | 14.76 | — | — | — | |
| Receivables Turnover, Industry | ||||||
| Health Care | 8.22 | 8.00 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Receivables turnover = Revenue ÷ Accounts receivable, net
= 2,909,800 ÷ 713,300 = 4.08
2 Click competitor name to see calculations.
Analysis of the five-year period from 2018 to 2022 reveals a trajectory of consistent revenue expansion accompanied by a substantial increase in net accounts receivable. While top-line growth remained strong throughout the period, the efficiency of credit collection exhibited volatility, culminating in a downward trend toward the end of the observed timeframe.
- Revenue and Asset Growth
- Revenue experienced an uninterrupted upward trend, growing from 1.03 billion US dollars in 2018 to approximately 2.91 billion US dollars by 2022. During this same interval, net accounts receivable increased from 226.7 million US dollars to 713.3 million US dollars. The growth in receivables outpaced the growth in revenue, particularly between 2021 and 2022, where receivables rose by approximately 38.7% while revenue grew by 18.8%.
- Receivables Turnover Efficiency
- The receivables turnover ratio demonstrated a lack of linear stability. An initial improvement was noted in 2019, with the ratio peaking at 5.16. However, the ratio subsequently declined, reaching a five-year low of 4.08 in 2022. This decline indicates that the company is taking longer to collect payments from customers relative to its sales volume.
- Operational Implications
- The divergence between revenue growth and receivables turnover suggests a potential slowdown in the cash conversion cycle. The reduction in the turnover ratio from 5.16 in 2019 to 4.08 in 2022 implies an increase in the average collection period, which may be attributed to more lenient credit terms offered to customers or a decrease in the effectiveness of collection processes.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Payables Turnover
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Cost of sales | 1,026,700) | 768,000) | 646,600) | 544,500) | 367,700) | |
| Accounts payable trade | 237,900) | 196,000) | 163,300) | 102,300) | 75,500) | |
| Short-term Activity Ratio | ||||||
| Payables turnover1 | 4.32 | 3.92 | 3.96 | 5.32 | 4.87 | |
| Benchmarks | ||||||
| Payables Turnover, Competitors2 | ||||||
| Abbott Laboratories | 4.15 | 4.21 | — | — | — | |
| Elevance Health Inc. | 7.47 | 7.59 | — | — | — | |
| Intuitive Surgical Inc. | 13.78 | 14.45 | — | — | — | |
| Medtronic PLC | 4.46 | 4.98 | — | — | — | |
| UnitedHealth Group Inc. | 7.26 | 7.63 | — | — | — | |
| Payables Turnover, Sector | ||||||
| Health Care Equipment & Services | 6.94 | 7.18 | — | — | — | |
| Payables Turnover, Industry | ||||||
| Health Care | 5.79 | 5.84 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Payables turnover = Cost of sales ÷ Accounts payable trade
= 1,026,700 ÷ 237,900 = 4.32
2 Click competitor name to see calculations.
The financial data indicates a period of significant expansion in operational scale, characterized by a consistent and substantial increase in both cost of sales and accounts payable trade from 2018 through 2022.
- Cost of Sales and Trade Payables Expansion
- A strong upward trajectory is observed in the cost of sales, which grew from US$ 367.7 million in 2018 to US$ 1,026.7 million by the end of 2022. In parallel, accounts payable trade rose from US$ 75.5 million to US$ 237.9 million. This concurrent growth reflects a scaling of procurement and production activities to support increased business volume.
- Payables Turnover Volatility
- The payables turnover ratio demonstrated a non-linear trend over the five-year period. After an initial increase from 4.87 in 2018 to a peak of 5.32 in 2019, the ratio declined sharply to 3.96 in 2020 and reached its lowest point of 3.92 in 2021. A moderate recovery to 4.32 was recorded in 2022.
- Working Capital Management Insights
- The decrease in the turnover ratio between 2019 and 2021 indicates that the company extended the duration of its payment cycle to suppliers. This shift suggests an improvement in bargaining power or a strategic decision to optimize working capital by retaining cash for longer periods. The subsequent rise in 2022 indicates a slight acceleration in the settlement of trade obligations compared to the previous two years, although the ratio remains below the levels seen in 2018 and 2019.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Working Capital Turnover
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Current assets | 3,668,800) | 3,684,400) | 3,424,800) | 1,969,400) | 1,699,500) | |
| Less: Current liabilities | 1,839,300) | 720,800) | 614,100) | 360,200) | 222,400) | |
| Working capital | 1,829,500) | 2,963,600) | 2,810,700) | 1,609,200) | 1,477,100) | |
| Revenue | 2,909,800) | 2,448,500) | 1,926,700) | 1,476,000) | 1,031,600) | |
| Short-term Activity Ratio | ||||||
| Working capital turnover1 | 1.59 | 0.83 | 0.69 | 0.92 | 0.70 | |
| Benchmarks | ||||||
| Working Capital Turnover, Competitors2 | ||||||
| Abbott Laboratories | 4.48 | 3.87 | — | — | — | |
| Elevance Health Inc. | 8.37 | 7.23 | — | — | — | |
| Intuitive Surgical Inc. | 1.29 | 1.22 | — | — | — | |
| Medtronic PLC | 2.97 | 2.15 | — | — | — | |
| UnitedHealth Group Inc. | — | — | — | — | — | |
| Working Capital Turnover, Sector | ||||||
| Health Care Equipment & Services | 25.59 | 16.28 | — | — | — | |
| Working Capital Turnover, Industry | ||||||
| Health Care | 11.30 | 8.57 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Working capital turnover = Revenue ÷ Working capital
= 2,909,800 ÷ 1,829,500 = 1.59
2 Click competitor name to see calculations.
Revenue exhibited a consistent upward trajectory from 2018 to 2022, increasing from 1,031,600 thousand USD to 2,909,800 thousand USD. In contrast, working capital followed a non-linear path, expanding significantly between 2018 and 2021—peaking at 2,963,600 thousand USD—before experiencing a substantial reduction to 1,829,500 thousand USD in 2022.
- Working Capital Turnover Volatility
- Between 2018 and 2021, the turnover ratio remained below 1.0, fluctuating between a low of 0.69 in 2020 and a high of 0.92 in 2019. This pattern indicates a period where the growth in working capital often outpaced or mirrored revenue growth, resulting in a relatively low efficiency in utilizing short-term assets to generate sales.
- Operational Efficiency Acceleration
- A significant shift in efficiency is observed in 2022, as the working capital turnover ratio rose sharply to 1.59. This nearly twofold increase from the previous year is attributed to the divergence between reaching peak revenue levels and a concurrent reduction in working capital, suggesting a more optimized management of short-term resources.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Average Inventory Processing Period
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Inventory turnover | 3.35 | 2.15 | 2.76 | 4.55 | 5.20 | |
| Short-term Activity Ratio (no. days) | ||||||
| Average inventory processing period1 | 109 | 170 | 132 | 80 | 70 | |
| Benchmarks (no. days) | ||||||
| Average Inventory Processing Period, Competitors2 | ||||||
| Abbott Laboratories | 118 | 102 | — | — | — | |
| Intuitive Surgical Inc. | 161 | 122 | — | — | — | |
| Medtronic PLC | 166 | 150 | — | — | — | |
| Average Inventory Processing Period, Sector | ||||||
| Health Care Equipment & Services | 12 | 11 | — | — | — | |
| Average Inventory Processing Period, Industry | ||||||
| Health Care | 46 | 46 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 3.35 = 109
2 Click competitor name to see calculations.
An analysis of short-term activity ratios reveals a fluctuating trend in inventory management efficiency over the five-year period from 2018 to 2022. A period of declining efficiency is observed between 2018 and 2021, followed by a corrective recovery in the final year.
- Inventory Turnover
- The inventory turnover ratio exhibited a consistent downward trend for four consecutive years, falling from a high of 5.20 in 2018 to a low of 2.15 in 2021. This decline indicates a reduction in the frequency with which inventory was sold and replaced. A reversal occurred in 2022, as the ratio rose to 3.35, signaling an improvement in inventory throughput and sales velocity.
- Average Inventory Processing Period
- Correspondingly, the average inventory processing period increased significantly from 70 days in 2018 to a peak of 170 days in 2021. This expansion reflects a substantial increase in the time inventory remained on hand before being converted into sales, which generally suggests higher carrying costs or slower demand. In 2022, this period contracted to 109 days, demonstrating a notable increase in operational efficiency, although the duration remains elevated compared to the 2018 and 2019 baselines.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Average Receivable Collection Period
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Receivables turnover | 4.08 | 4.76 | 4.50 | 5.16 | 4.55 | |
| Short-term Activity Ratio (no. days) | ||||||
| Average receivable collection period1 | 89 | 77 | 81 | 71 | 80 | |
| Benchmarks (no. days) | ||||||
| Average Receivable Collection Period, Competitors2 | ||||||
| Abbott Laboratories | 52 | 55 | — | — | — | |
| Elevance Health Inc. | 19 | 18 | — | — | — | |
| Intuitive Surgical Inc. | 55 | 50 | — | — | — | |
| Medtronic PLC | 64 | 66 | — | — | — | |
| UnitedHealth Group Inc. | 20 | 18 | — | — | — | |
| Average Receivable Collection Period, Sector | ||||||
| Health Care Equipment & Services | 25 | 25 | — | — | — | |
| Average Receivable Collection Period, Industry | ||||||
| Health Care | 44 | 46 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 4.08 = 89
2 Click competitor name to see calculations.
The analysis of short-term operating activity ratios reveals a period of volatility in the management of accounts receivable between 2018 and 2022. Efficiency in credit collection peaked in 2019, followed by a general trend of decelerating collection speeds and declining turnover ratios.
- Receivables Turnover
- The receivables turnover ratio experienced an initial increase from 4.55 in 2018 to a five-year peak of 5.16 in 2019. Subsequent years showed a general decline, with the ratio dropping to 4.50 in 2020, recovering slightly to 4.76 in 2021, and ultimately reaching a period low of 4.08 by December 31, 2022. This downward movement indicates a reduction in the efficiency with which the company converts its receivables into cash over the annual cycle.
- Average Receivable Collection Period
- The collection period mirrors the volatility of the turnover ratio, with the most efficient performance recorded in 2019 at 71 days. A significant increase to 81 days occurred in 2020, followed by a slight improvement to 77 days in 2021. The period concluded with a notable extension of the collection cycle to 89 days in 2022, marking the longest duration for receivable recovery within the analyzed timeframe.
The extension of the average receivable collection period from 71 days in 2019 to 89 days in 2022 suggests a slowing in the conversion of credit sales to liquid assets. This trend indicates either a shift toward more lenient credit terms for customers or a decrease in the promptness of customer payments, which may place additional pressure on short-term working capital management.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Operating Cycle
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Average inventory processing period | 109 | 170 | 132 | 80 | 70 | |
| Average receivable collection period | 89 | 77 | 81 | 71 | 80 | |
| Short-term Activity Ratio | ||||||
| Operating cycle1 | 198 | 247 | 213 | 151 | 150 | |
| Benchmarks | ||||||
| Operating Cycle, Competitors2 | ||||||
| Abbott Laboratories | 170 | 157 | — | — | — | |
| Intuitive Surgical Inc. | 216 | 172 | — | — | — | |
| Medtronic PLC | 230 | 216 | — | — | — | |
| Operating Cycle, Sector | ||||||
| Health Care Equipment & Services | 37 | 36 | — | — | — | |
| Operating Cycle, Industry | ||||||
| Health Care | 90 | 92 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= 109 + 89 = 198
2 Click competitor name to see calculations.
The operating cycle exhibited significant volatility between 2018 and 2022, characterized by a substantial expansion in the duration required to convert current assets into cash, followed by a partial contraction in the final year.
- Average Inventory Processing Period
- A pronounced upward trend was observed from 2018 to 2021, with the processing period increasing from 70 days to a peak of 170 days. This indicates a significant slowdown in inventory turnover during this period. However, a sharp decline to 109 days occurred in 2022, suggesting an improvement in inventory management or a shift in demand patterns.
- Average Receivable Collection Period
- The collection period remained relatively stable over the five-year horizon, fluctuating between a low of 71 days in 2019 and a high of 89 days in 2022. While the period was largely consistent through 2021, the increase to 89 days in 2022 indicates a marginal extension in the time required to collect payments from customers.
- Overall Operating Cycle Dynamics
- The total operating cycle mirrored the fluctuations of the inventory processing period, rising from 150 days in 2018 to a peak of 247 days in 2021. The subsequent reduction to 198 days in 2022 was primarily driven by the significant decrease in inventory holding time, which more than offset the slight increase in the receivable collection period.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Average Payables Payment Period
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Payables turnover | 4.32 | 3.92 | 3.96 | 5.32 | 4.87 | |
| Short-term Activity Ratio (no. days) | ||||||
| Average payables payment period1 | 85 | 93 | 92 | 69 | 75 | |
| Benchmarks (no. days) | ||||||
| Average Payables Payment Period, Competitors2 | ||||||
| Abbott Laboratories | 88 | 87 | — | — | — | |
| Elevance Health Inc. | 49 | 48 | — | — | — | |
| Intuitive Surgical Inc. | 26 | 25 | — | — | — | |
| Medtronic PLC | 82 | 73 | — | — | — | |
| UnitedHealth Group Inc. | 50 | 48 | — | — | — | |
| Average Payables Payment Period, Sector | ||||||
| Health Care Equipment & Services | 53 | 51 | — | — | — | |
| Average Payables Payment Period, Industry | ||||||
| Health Care | 63 | 63 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ 4.32 = 85
2 Click competitor name to see calculations.
The analysis of the operating activity ratios reveals a period of volatility in the management of obligations to suppliers between 2018 and 2022. The company experienced a shift in its payment efficiency, characterized by a notable extension of the payment cycle during the middle of the observed period, followed by a partial contraction in the final year.
- Payables Turnover
- The payables turnover ratio increased from 4.87 in 2018 to a peak of 5.32 in 2019, indicating a higher frequency of supplier payments. However, a significant decline followed, with the ratio dropping to 3.96 in 2020 and reaching a low of 3.92 in 2021. This downward trend reflects a decrease in the rate at which obligations were settled. A partial recovery occurred in 2022, as the ratio rose to 4.32.
- Average Payables Payment Period
- The time required to settle accounts payable fluctuated, starting at 75 days in 2018 and decreasing to 69 days in 2019. A sharp increase in the payment duration was observed in 2020, where the period extended to 92 days, peaking at 93 days in 2021. This expansion suggests a deliberate or operational slowing of cash outflows to suppliers during this window. By 2022, the period contracted to 85 days, indicating a moderate acceleration in the settlement of liabilities compared to the 2020-2021 peak.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Cash Conversion Cycle
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Average inventory processing period | 109 | 170 | 132 | 80 | 70 | |
| Average receivable collection period | 89 | 77 | 81 | 71 | 80 | |
| Average payables payment period | 85 | 93 | 92 | 69 | 75 | |
| Short-term Activity Ratio | ||||||
| Cash conversion cycle1 | 113 | 154 | 121 | 82 | 75 | |
| Benchmarks | ||||||
| Cash Conversion Cycle, Competitors2 | ||||||
| Abbott Laboratories | 82 | 70 | — | — | — | |
| Intuitive Surgical Inc. | 190 | 147 | — | — | — | |
| Medtronic PLC | 148 | 143 | — | — | — | |
| Cash Conversion Cycle, Sector | ||||||
| Health Care Equipment & Services | -16 | -15 | — | — | — | |
| Cash Conversion Cycle, Industry | ||||||
| Health Care | 27 | 29 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= 109 + 89 – 85 = 113
2 Click competitor name to see calculations.
The cash conversion cycle exhibited a significant upward trend between 2018 and 2021, peaking at 154 days before contracting to 113 days in 2022. This volatility indicates a period of decreased working capital efficiency, primarily driven by fluctuations in inventory management rather than receivables or payables.
- Average Inventory Processing Period
- A substantial increase is observed from 70 days in 2018 to a peak of 170 days in 2021. This expansion suggests a significant buildup of inventory or a slowdown in turnover during this period. However, a sharp reduction to 109 days in 2022 indicates a correction in inventory levels or improved operational efficiency in moving products.
- Average Receivable Collection Period
- Collection periods remained relatively stable throughout the period, fluctuating within a range of 71 to 89 days. While there was a slight dip in 2019, the period ended at its highest point of 89 days in 2022, suggesting a marginal increase in the time required to convert receivables into cash.
- Average Payables Payment Period
- The period for paying suppliers lengthened from 75 days in 2018 to 93 days by 2021, before decreasing to 85 days in 2022. The trend between 2018 and 2021 indicates a strategic extension of payment terms, which served to partially offset the cash outflows caused by the expanding inventory processing period.
Overall, the cash conversion cycle's trajectory was heavily influenced by the inventory processing period, which acted as the primary driver of liquidity pressure between 2020 and 2021. The reduction in the cycle to 113 days in 2022 suggests a recovery in operating efficiency, although the cycle remains higher than the 2018 baseline of 75 days.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?